dr. fanale on challenges facing treatments in t-cell lymphoma
Published 7 years ago • 192 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:50
dr. fanale on clinical trials for t-cell lymphoma
-
1:50
dr. michelle fanale on frontline brentuximab in subtypes of lymphoma
-
1:33
dr. fanale on brentuximab vedotin as frontline treatment for lymphoma
-
0:54
challenges impacting treatment of cutaneous and peripheral t-cell lymphomas
-
1:03
dr. foss on the unmet need in cutaneous t-cell lymphoma
-
2:57
challenges in the treatment of follicular lymphoma
-
3:55
the standard of care in t-cell lymphoma: challenges and future outlooks
-
2:19
the addition of venetoclax to hyper-cvad-nelarabine and pegylated asparagine in t-all
-
1:19
potential challenges in the future treatment of mantle cell lymphoma
-
1:18
dr. batlevi on challenges faced in follicular lymphoma management
-
1:27
patient selection for newly approved agents in t-cell lymphoma
-
15:03
treatment selection for peripheral t-cell lymphomas
-
2:27
dr. fanale discusses brentuximab vedotin in cd30-positive lymphomas
-
0:47
dr. goy on the challenges of treating hodgkin's lymphoma
-
2:46
challenges in diagnosing and treating ctcl
-
1:24
dr. flinn on car t-cell therapy in non-hodgkin lymphoma
-
1:24
ctcl management: the challenges faced by clinicians
-
2:26
challenges of diagnosing cutaneous t-cell lymphoma (ctcl)
-
4:50
ongoing challenges in treating mantle cell lymphoma